September 10, 2025Journal of Urologic OncologyOpen Access

Adverse Prognosis in Dialysis Patients Undergoing Systemic Therapy for Metastatic Renal Cell Carcinoma: A Retrospective Study

View Full Paper

Ask AI

Bookmark

Authors

SIShun IwasaKeio University RMRyuichi MizunoSt. Marianna University School of Medicine KFKeishiro FukumotoKeio University

Discussion

Member takes

Implication

Retrospective analysis reveals shorter overall survival and cancer-specific survival in dialysis patients with metastatic renal cell carcinoma, highlighting treatment challenges.

Key Points

Overall survival and cancer-specific survival were significantly shorter in dialysis patients with metastatic RCC compared to nondialysis patients.
Median overall survival in dialysis patients was 21.2 months, significantly less than in nondialysis patients (p=0.001).
This retrospective study involved 253 patients, with 17 on dialysis, using the Kaplan-Meier method to assess survival rates.
The findings suggest that dialysis patients face unique challenges in treatment outcomes for metastatic RCC, necessitating further investigation.

Cite This Study

Iwasa et al. (2025) studied this question.

synapsesocial.com/papers/68c23dc5b210217d6478f3be https://doi.org/10.22465/juo.255000200010

View Full Paper

Ask AI

Bookmark

Implication

Retrospective analysis reveals shorter overall survival and cancer-specific survival in dialysis patients with metastatic renal cell carcinoma, highlighting treatment challenges.